DK0856007T3 - cyclopeptidderivater - Google Patents

cyclopeptidderivater

Info

Publication number
DK0856007T3
DK0856007T3 DK96934675T DK96934675T DK0856007T3 DK 0856007 T3 DK0856007 T3 DK 0856007T3 DK 96934675 T DK96934675 T DK 96934675T DK 96934675 T DK96934675 T DK 96934675T DK 0856007 T3 DK0856007 T3 DK 0856007T3
Authority
DK
Denmark
Prior art keywords
cyclopeptide derivatives
cyclopeptide
derivatives
Prior art date
Application number
DK96934675T
Other languages
English (en)
Inventor
Alfred Jonczyk
Lawrence Simon
Beate Diefenbach
Arne Sutter
Horst Kessler
Original Assignee
Biomet Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomet Deutschland Gmbh filed Critical Biomet Deutschland Gmbh
Application granted granted Critical
Publication of DK0856007T3 publication Critical patent/DK0856007T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96934675T 1995-10-18 1996-10-14 cyclopeptidderivater DK0856007T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19538741A DE19538741A1 (de) 1995-10-18 1995-10-18 Cyclopeptidderivate
PCT/EP1996/004462 WO1997014716A1 (de) 1995-10-18 1996-10-14 Cyclopeptidderivate

Publications (1)

Publication Number Publication Date
DK0856007T3 true DK0856007T3 (da) 2004-08-09

Family

ID=7775137

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96934675T DK0856007T3 (da) 1995-10-18 1996-10-14 cyclopeptidderivater

Country Status (24)

Country Link
US (1) US6566491B2 (da)
EP (1) EP0856007B1 (da)
JP (1) JP2000500432A (da)
KR (1) KR100475397B1 (da)
CN (1) CN1118475C (da)
AR (1) AR008983A1 (da)
AT (1) ATE264874T1 (da)
AU (1) AU716847B2 (da)
BR (1) BR9611358A (da)
CA (1) CA2234980C (da)
CZ (1) CZ288379B6 (da)
DE (2) DE19538741A1 (da)
DK (1) DK0856007T3 (da)
ES (1) ES2220992T3 (da)
HU (1) HU226594B1 (da)
NO (1) NO981752L (da)
PL (1) PL186914B1 (da)
PT (1) PT856007E (da)
RU (1) RU2174520C2 (da)
SK (1) SK284752B6 (da)
TW (1) TW570928B (da)
UA (1) UA60296C2 (da)
WO (1) WO1997014716A1 (da)
ZA (1) ZA968770B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753230A (en) 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
US6500924B1 (en) 1996-05-31 2002-12-31 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
US7053041B1 (en) 1996-05-31 2006-05-30 The Scripps Research Institute Methods and compositions useful for inhibition of αvβ5mediated angiogenesis
PL330240A1 (en) * 1996-05-31 1999-05-10 Scripps Research Inst Methods and compositions useful in inhibiting angiogenesis in which alphavbeta5 acts as intermediary
DE19755800A1 (de) * 1997-12-16 1999-06-17 Merck Patent Gmbh Cyclopeptidderivate
UA71608C2 (en) 1999-03-11 2004-12-15 Merck Patent Gmbh A method for producing the cyclic pentapeptide
DE19933173A1 (de) 1999-07-15 2001-01-18 Merck Patent Gmbh Cyclische Peptidderivate als Inhibitoren des Integrins alpha¶v¶beta¶6¶
WO2002040073A1 (en) 2000-11-20 2002-05-23 Université De Genève Endosseous implant
RU2311177C2 (ru) * 2001-08-01 2007-11-27 Мерк Патент Гмбх Ингибиторы интегрина для лечения заболевания глаз
RU2360686C1 (ru) * 2008-02-14 2009-07-10 Михаил Владимирович Кутушов Лекарственное средство для лечения онкологических заболеваний
RU2477601C1 (ru) * 2011-08-09 2013-03-20 Лев Петрович Петренко Способ формирования структуры кроны виноградника (вариант русской логики - версия 5)
CN110128490B (zh) * 2018-02-09 2021-03-16 厦门诺康得生物科技有限公司 一种用于免疫细胞表面修饰的糖类衍生物及其应用
US10494403B2 (en) * 2018-03-06 2019-12-03 Ciphore Biomed Technology Limited Company Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren

Also Published As

Publication number Publication date
AR008983A1 (es) 2000-03-08
US20020032306A1 (en) 2002-03-14
RU2174520C2 (ru) 2001-10-10
NO981752L (no) 1998-06-16
EP0856007A1 (de) 1998-08-05
PL327238A1 (en) 1998-12-07
KR19990064333A (ko) 1999-07-26
PL186914B1 (pl) 2004-03-31
HUP9803000A2 (hu) 1999-06-28
EP0856007B1 (de) 2004-04-21
CZ288379B6 (en) 2001-06-13
ES2220992T3 (es) 2004-12-16
ZA968770B (en) 1997-05-27
SK47398A3 (en) 1998-11-04
ATE264874T1 (de) 2004-05-15
CN1202907A (zh) 1998-12-23
HUP9803000A3 (en) 2001-01-29
AU7292196A (en) 1997-05-07
CZ111198A3 (cs) 1998-09-16
NO981752D0 (no) 1998-04-17
TW570928B (en) 2004-01-11
PT856007E (pt) 2004-09-30
HU226594B1 (en) 2009-04-28
CN1118475C (zh) 2003-08-20
KR100475397B1 (ko) 2005-05-16
UA60296C2 (uk) 2003-10-15
DE59610991D1 (en) 2004-05-27
CA2234980C (en) 2009-05-05
US6566491B2 (en) 2003-05-20
AU716847B2 (en) 2000-03-09
JP2000500432A (ja) 2000-01-18
WO1997014716A1 (de) 1997-04-24
DE19538741A1 (de) 1997-04-24
SK284752B6 (sk) 2005-11-03
BR9611358A (pt) 1999-03-09
CA2234980A1 (en) 1997-04-24

Similar Documents

Publication Publication Date Title
DE69611361T2 (de) Chinazolin-derivate
DE69522717D1 (de) Chinazolinderivate
NO974103D0 (no) Arylsulfonylaminohydroksamsyre-derivater
DE69610698D1 (de) Chinazolin-derivate
PT833828E (pt) Derivados de rapamicina
BR9611834A (pt) Derivados de oximetóxi-3-aril-pirona
NO964667D0 (no) Purin-6-on-derivater
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
DE69601527T2 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
ATE264874T1 (de) Cyclopeptidderivate
ATE240307T1 (de) Diarylalkenylamin-derivate
DE69627830D1 (de) Pyrazol-derivate
DE59607054D1 (de) 4-Amino-benzoylguanidin-Derivate
ATE177102T1 (de) Chromanderivate
DE59610106D1 (de) Fluorbenzylether-Derivate
DK0948525T3 (da) Cyclopeptidderivater
DE69624122T2 (de) Aza-anthracyclinone-derivate
BR9603508A (pt) Derivados de alquenil-benzoilguanidina
ATE202088T1 (de) 4-mercapto-benzoylguanidin-derivate
DE69620514T2 (de) 5-aminoflavon-derivate
NO982280L (no) Cyklopeptider
ATA45796A (de) Lysin-prolin-derivate
BR9603733A (pt) Derivados de cloropiridilcarbonila